Both in Surgical Instruments
Penumbra vs Haemonetics
Over the past year PEN returned +41.5% and HAE returned +139.3%; their daily moves had a correlation of 0.42.
PEN +41.5% HAE +139.3%Growth of $1, one year, split-adjusted
| Metric | PEN | HAE |
|---|---|---|
| Price | $320.02 | $120.28 |
| Market cap | $12.61B | $5.47B |
| Today | −0.41% | +0.12% |
| 1 month | +0.9% | +14.9% |
| 6 months | −1.2% | +116.3% |
| Year to date | +2.9% | +50.1% |
| 1 year | +40.7% | +140.5% |
| Revenue growth (YoY) | +15.6% | +5.6% |
| Gross margin | 68.3% | 59.8% |
| Net margin | 10.3% | 9.7% |
| P/E (TTM) | 80.3× | 56.8× |
| Price / sales | 8.1× | 4.0× |
| Net cash | $652.2M | -$950.8M |
| Dividend yield | — | — |
| Volatility (60d) | 7.7% | 48.5% |
| Short % of float | 5.9% | 7.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).